Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 8 (2011), Issue 10 (October)

1. Sleep disturbance in euthymic bipolar patients.
   J Psychopharmacol. [Abstract] [Full-text]
2. Screening for bipolar disorder among outpatients with substance use disorders.
   Eur Psychiatry. [Abstract] [Full-text]
3. Mania following addition of hydroxytryptophan to monoamine oxidase inhibitor.
   Gen Hosp Psychiatry. [Abstract] [Full-text]
4. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder.
   J Affect Disord. [Abstract] [Full-text]
5. Progression of amygdala volumetric abnormalities in adolescents after their first manic episode.
   J Am Acad Child Adolesc Psychiatry, 50(10): 1017-26. [Abstract] [Full-text]
6. Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified.
   J Am Acad Child Adolesc Psychiatry, 50(10): 1001-1016.e3. [Abstract] [Full-text]
7. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
   Pharmacogenomics. [Abstract] [Full-text]
8. Impaired functioning in euthymic patients with bipolar disorder - HSV-1 as a predictor.
   Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
9. Striatal volumes in pediatric bipolar patients with and without comorbid ADHD.
   Psychiatry Res, 194(1): 14-20. [Abstract] [Full-text]
10. Altered transfer of visual motion information to parietal association cortex in untreated first-episode psychosis: Implications for pursuit eye tracking.
    Psychiatry Res, 194(1): 30-8. [Abstract] [Full-text]
11. Cross-cultural comparisons on Wisconsin Card Sorting Test performance in euthymic patients with bipolar disorder.
    Psychiatry Res, 189(3): 469-71. [Abstract] [Full-text]
12. Comparison of depressive episodes in bipolar disorder and in major depressive disorder within bipolar disorder pedigrees.
    Br J Psychiatry, 199: 303-9. [Abstract] [Full-text]
13. Progression of amygdala volumetric abnormalities in adolescents after their first manic episode.
    J Am Acad Child Adolesc Psychiatry, 50(10): 1017-26. [Abstract] [Full-text]
14. Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified.
    J Am Acad Child Adolesc Psychiatry, 50(10): 1001-16.e3. [Abstract] [Full-text]
15. Striatal volumes in pediatric bipolar patients with and without comorbid ADHD.
    Psychiatry Res, 194(1): 14-20. [Abstract] [Full-text]
16. Altered transfer of visual motion information to parietal association cortex in untreated first-episode psychosis: implications for pursuit eye tracking.
    Psychiatry Res, 194(1): 30-8. [Abstract] [Full-text]
17. Cross-cultural comparisons on Wisconsin Card Sorting Test performance in euthymic patients with bipolar disorder.
    Psychiatry Res, 189(3): 469-71. [Abstract] [Full-text]
18. Theory of mind and facial emotion recognition in euthymic bipolar I and bipolar II disorders.
    Psychiatry Res, 189(3): 379-84. [Abstract] [Full-text]
19. Comparison of depressive episodes in bipolar disorder and in major depressive disorder within bipolar disorder pedigrees.
    Br J Psychiatry, 199(4): 303-9. [Abstract] [Full-text]
20. Validity of the Chinese version Mood Disorder Questionnaire (MDQ) and the optimal cutoff screening bipolar disorders.
    Psychiatry Res, 189(3): 446-50. [Abstract] [Full-text]
21. After the black box warning: predictors of psychotropic treatment choices for older patients with dementia.
    Psychiatr Serv, 62(10): 1207-14. [Abstract] [Full-text]
22. Untreated posttraumatic stress among persons with severe mental illness despite marked trauma and symptomatology.
    Psychiatr Serv, 62(10): 1201-6. [Abstract] [Full-text]
23. Psychiatric and general medical conditions comorbid with bipolar disorder in the national hospital discharge survey.
    Psychiatr Serv, 62(10): 1152-8. [Abstract] [Full-text]
24. Service use among patients with serious mental illnesses who presented with physical symptoms at intake.
    Psychiatr Serv, 62(10): 1146-51. [Abstract] [Full-text]
25. Absolute risk of suicide after first hospital contact in mental disorder.
    Arch Gen Psychiatry, 68(10): 1058-64. [Abstract] [Full-text]
26. A high-risk study of bipolar disorder: childhood clinical phenotypes as precursors of major mood disorders.
    Arch Gen Psychiatry, 68(10): 1012-20. [Abstract] [Full-text]
27. New dimensions in the quantitative classification of mental illness.
    Arch Gen Psychiatry, 68(10): 1003-11. [Abstract] [Full-text]
28. Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region.
    Acta Neuropathol. [Abstract] [Full-text]
29. Do patients with bipolar disorder drink alcohol for different reasons when depressed, manic or euthymic?
    J Affect Disord. [Abstract] [Full-text]
30. Stutter exacerbated by lithium in a pediatric patient with bipolar disorder.
    Ann Pharmacother, 45(10): e57. [Abstract] [Full-text]
31. Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior.
    Am J Psychiatry, 168(10): 1050-6. [Abstract] [Full-text]
32. After the black box warning: predictors of psychotropic treatment choices for older patients with dementia.
    Psychiatr Serv, 62(10): 1207-14. [Abstract] [Full-text]
33. Untreated posttraumatic stress among persons with severe mental illness despite marked trauma and symptomatology.
    Psychiatr Serv, 62(10): 1201-6. [Abstract] [Full-text]
34. Psychiatric and general medical conditions comorbid with bipolar disorder in the National Hospital Discharge Survey.
    Psychiatr Serv, 62(10): 1152-8. [Abstract] [Full-text]
35. Service use among patients with serious mental illnesses who presented with physical symptoms at intake.
    Psychiatr Serv, 62(10): 1146-51. [Abstract] [Full-text]
36. Absolute risk of suicide after first hospital contact in mental disorder.
    Arch Gen Psychiatry, 68(10): 1058-64. [Abstract] [Full-text]
37. A high-risk study of bipolar disorder. Childhood clinical phenotypes as precursors of major mood disorders.
    Arch Gen Psychiatry, 68(10): 1012-20. [Abstract] [Full-text]
38. New dimensions in the quantitative classification of mental illness.
    Arch Gen Psychiatry, 68(10): 1003-11. [Abstract] [Full-text]
39. Stutter exacerbated by lithium in a pediatric patient with bipolar disorder.
    Ann Pharmacother, 45(10): e57. [Abstract] [Full-text]
40. Predictors of excellent response to lithium: results from a nationwide register-based study.
    Int Clin Psychopharmacol, 26(6): 323-8. [Abstract] [Full-text]
41. Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior.
    Am J Psychiatry, 168(10): 1050-6. [Abstract] [Full-text]
42. Association analysis of ANK3 gene variants in nordic bipolar disorder and schizophrenia case-control samples.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
43. Long-term impact of the life goals group therapy program for bipolar patients.
    J Affect Disord. [Abstract] [Full-text]
44. Recent genomic advances in schizophrenia.
    Clin Genet. [Abstract] [Full-text]
45. Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E(2) concentration in rat brain.
    J Neurochem, 119(2): 364-76. [Abstract] [Full-text]
46. Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.
    J Neurochem, 119(2): 364-76. [Abstract] [Full-text]
47. Cholecystokinin system genes: Associations with panic and other psychiatric disorders.
    J Affect Disord. [Abstract] [Full-text]
48. Clinical and dimensional characteristics of euthymic bipolar patients with or without suicidal behavior.
    Eur Psychiatry. [Abstract] [Full-text]
49. Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: What have we learnt?
    Neurosci Biobehav Rev. [Abstract] [Full-text]
50. Chronic valproate treatment blocks D(2)-like receptor-mediated brain signaling via arachidonic acid in rats.
    Neuropharmacology, 61(8): 1256-64. [Abstract] [Full-text]
51. Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.
    Neuropharmacology, 61(8): 1256-64. [Abstract] [Full-text]
52. Effects of anxiety on the long-term course of depressive disorders.
    Br J Psychiatry. [Abstract] [Full-text]
53. Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders.
    Hum Mol Genet. [Abstract] [Full-text]
54. A case of tremor reduction and almost complete ageusia under bilateral thalamic (VIM) deep brain stimulation in essential tremor-a therapeutic dilemma.
    Acta Neurochir (Wien). [Abstract] [Full-text]
55. Practice of Electroconvulsive Therapy in a Tertiary Care Hospital in Pakistan.
    J ECT. [Abstract] [Full-text]
56. Electroconvulsive Therapy in Norway: Rates of Use, Clinical Characteristics, Diagnoses, and Attitude.
    J ECT. [Abstract] [Full-text]
57. Psychosis and Dandy-Walker complex: report of four cases.
    Gen Hosp Psychiatry. [Abstract] [Full-text]
58. Genome-wide association study on bipolar disorder in the Bulgarian population.
    Genes Brain Behav, 10(7): 789-797. [Abstract] [Full-text]
59. Predictors of clinical trial dropout in individuals with co-occurring bipolar disorder and alcohol dependence.
    Drug Alcohol Depend, 118(2): 493-6. [Abstract] [Full-text]
60. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.
    Lancet, 378(9799): 1306-15. [Abstract] [Full-text]
61. Genome-wide association study on bipolar disorder in the Bulgarian population.
    Genes Brain Behav, 10(7): 789-97. [Abstract] [Full-text]
62. Predictors of clinical trial dropout in individuals with co-occurring bipolar disorder and alcohol dependence.
    Drug Alcohol Depend, 118(2): 493-6. [Abstract] [Full-text]
63. Reconsidering the Association Between the Major Histocompatibility Complex and Bipolar Disorder.
    J Mol Neurosci. [Abstract] [Full-text]
64. Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?
    Mol Psychiatry. [Abstract] [Full-text]
65. Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder.
    BMC Psychiatry, 11(1): 164. [Abstract] [Full-text]
66. Association between hippocampal volume and P300 event related potential in psychosis: Support for the Kraepelinian divide.
    Neuroimage. [Abstract] [Full-text]
67. Cerebral asymmetry in schizophrenia.
    Neuroscientist, 17(5): 456-67. [Abstract] [Full-text]
68. Cerebral asymmetry in schizophrenia.
    Neuroscientist, 17(5): 456-67. [Abstract] [Full-text]
69. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?
    Brain Behav Immun, 25(8): 1530-43. [Abstract] [Full-text]
70. The relationship of manic episodes and drug abuse to sexual risk behavior in patients with co-occurring bipolar and substance use disorders: a 15-month prospective analysis.
    AIDS Behav, 15(8): 1829-33. [Abstract] [Full-text]
71. The genetics of antipsychotic induced tremors: A genome-wide pathway analysis on the STEP-BD SCP sample.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
72. No Correlation between Lithium Serum Levels and Psychopathological Features during the Euthymic Interval of Patients with Recurrent Affective Disorder.
    Pharmacopsychiatry. [Abstract] [Full-text]
73. Pharmacoresistant Convulsions and Visual Hallucinations around Two Weeks after Selegiline Overdose: A Case Report.
    Pharmacopsychiatry. [Abstract] [Full-text]
74. Behavioral and neurochemical effects of sodium butyrate in an animal model of mania.
    Behav Pharmacol. [Abstract] [Full-text]
75. Identification of a Glycogen Synthase Kinase-3β Inhibitor that Attenuates Hyperactivity in CLOCK Mutant Mice.
    ChemMedChem, 6(9): 1593-602. [Abstract] [Full-text]
76. Lithium-associated hyperparathyroidism: surgical strategies in the era of minimally invasive parathyroidectomy.
    World J Surg, 35(11): 2432-9. [Abstract] [Full-text]
77. Effects of long-term combination treatment with valproate and atypical antipsychotics on bone mineral density and bone metabolism in premenopausal patients with bipolar disorder: a preliminary study.
    Psychiatry Investig, 8(3): 256-61. [Abstract] [Full-text]
78. Reduced Fertility and Fecundity among Patients with Bipolar I Disorder and Schizophrenia in Egypt.
    Psychiatry Investig, 8(3): 214-20. [Abstract] [Full-text]
79. Effect of initial ziprasidone dose on treatment outcome of korean patients with acute manic or mixed episodes.
    Psychiatry Investig, 8(3): 207-13. [Abstract] [Full-text]
80. Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells.
    Innate Immun. [Abstract] [Full-text]
81. Analysis of association between common SNPs in ErbB4 and bipolar affective disorder, major depressive disorder and schizophrenia in the Han Chinese population.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
82. Analysis of complete mitochondrial genomes of patients with schizophrenia and bipolar disorder.
    J Hum Genet. [Abstract] [Full-text]
83. Altered tryptophan and alanine transport in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD): an in vitro study.
    Behav Brain Funct, 7: 40. [Abstract] [Full-text]
84. The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome.
    J Neurochem, 119(3): 617-629. [Abstract] [Full-text]
85. Altered tryptophan and alanine transport in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD): an in vitro study.
    Behav Brain Funct, 7: 40. [Abstract] [Full-text]
86. The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome.
    J Neurochem, 119(3): 617-29. [Abstract] [Full-text]
87. Low anxiety disorder comorbidity rate in bipolar disorders in Han Chinese in Taiwan.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
88. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: The Schizo-Bipolar Scale.
    Schizophr Res. [Abstract] [Full-text]
89. Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses.
    Schizophr Res. [Abstract] [Full-text]
90. Differences in demographic composition and in work, social, and functional limitations among the populations with unipolar depression and bipolar disorder: Results from a nationally representative sample.
    Health Qual Life Outcomes, 9(1): 90. [Abstract] [Full-text]
91. Novel glutamatergic agents for major depressive disorder and bipolar disorder.
    Pharmacol Biochem Behav. [Abstract] [Full-text]
92. Overexpression of reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder.
    Neuropsychopharmacology, 36(12): 2395-405. [Abstract] [Full-text]
93. In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.
    J Mol Model, 17(10): 2559-67. [Abstract] [Full-text]
94. Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder.
    Neuropsychopharmacology, 36(12): 2395-405. [Abstract] [Full-text]
95. In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.
    J Mol Model, 17(10): 2559-67. [Abstract] [Full-text]
96. Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia.
    Neurosci Lett. [Abstract] [Full-text]
97. Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies.
    Early Hum Dev. [Abstract] [Full-text]
98. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder.
    Eur Neuropsychopharmacol. [Abstract] [Full-text]
99. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.
    Psychol Med. [Abstract] [Full-text]
100. Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues.
     Neuroscience. [Abstract] [Full-text]
101. Evaluation of basal ganglia, brainstem raphe and ventricles in bipolar disorder by transcranial sonography.
     Psychiatry Res, 194(2): 190-7. [Abstract] [Full-text]
102. Valproate protects the retina from endoplasmic reticulum stress-induced apoptosis after ischemia-reperfusion injury.
     Neurosci Lett, 504(2): 88-92. [Abstract] [Full-text]
103. Voxel-based morphometry of patients with schizophrenia or bipolar I disorder: A matched control study.
     Psychiatry Res, 194(2): 149-56. [Abstract] [Full-text]
104. Normal amygdala activation but deficient ventrolateral prefrontal activation in adults with bipolar disorder during euthymia.
     Neuroimage, 59(1): 738-44. [Abstract] [Full-text]
105. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.
     J Psychiatr Res, 45(11): 1432-8. [Abstract] [Full-text]
106. Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders.
     Neuropharmacology, 62(1): 237-46. [Abstract] [Full-text]
107. P11 expression and PET in bipolar disorders.
     J Psychiatr Res, 45(11): 1426-31. [Abstract] [Full-text]
108. Interacting mechanisms of impulsivity in bipolar disorder and antisocial personality disorder.
     J Psychiatr Res, 45(11): 1477-82. [Abstract] [Full-text]
109. RT-qPCR study on post-mortem brain samples from patients with major psychiatric disorders: Reference genes and specimen characteristics.
     J Psychiatr Res, 45(11): 1411-8. [Abstract] [Full-text]
110. Successful reintroduction of valproic acid after the occurrence of pancytopenia.
     Am J Geriatr Pharmacother, 9(5): 351-3. [Abstract] [Full-text]
111. Evaluation of basal ganglia, brainstem raphe and ventricles in bipolar disorder by transcranial sonography.
     Psychiatry Res, 194(2): 190-7. [Abstract] [Full-text]
112. Valproate protects the retina from endoplasmic reticulum stress-induced apoptosis after ischemia-reperfusion injury.
     Neurosci Lett, 504(2): 88-92. [Abstract] [Full-text]
113. Voxel-based morphometry of patients with schizophrenia or bipolar I disorder: a matched control study.
     Psychiatry Res, 194(2): 149-56. [Abstract] [Full-text]
114. Normal amygdala activation but deficient ventrolateral prefrontal activation in adults with bipolar disorder during euthymia.
     Neuroimage, 59(1): 738-44. [Abstract] [Full-text]
115. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.
     J Psychiatr Res, 45(11): 1432-8. [Abstract] [Full-text]
116. Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders.
     Neuropharmacology, 62(1): 237-46. [Abstract] [Full-text]
117. P11 expression and PET in bipolar disorders.
     J Psychiatr Res, 45(11): 1426-31. [Abstract] [Full-text]
118. Interacting mechanisms of impulsivity in bipolar disorder and antisocial personality disorder.
     J Psychiatr Res, 45(11): 1477-82. [Abstract] [Full-text]
119. RT-qPCR study on post-mortem brain samples from patients with major psychiatric disorders: reference genes and specimen characteristics.
     J Psychiatr Res, 45(11): 1411-8. [Abstract] [Full-text]
120. Are screening scales for bipolar disorder good enough to be used in clinical practice?
     Compr Psychiatry, 52(6): 600-6. [Abstract] [Full-text]
121. Is there a relationship between attention deficit/hyperactivity disorder and manic symptoms among children with mental retardation of unknown etiology?
     Compr Psychiatry, 52(6): 644-9. [Abstract] [Full-text]
122. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
     Compr Psychiatry, 52(6): 613-22. [Abstract] [Full-text]
123. Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies.
     Front Mol Neurosci, 4: 24. [Abstract] [Full-text]
124. Expression profiling in neuropsychiatric disorders: Emphasis on glutamate receptors in bipolar disorder.
     Pharmacol Biochem Behav. [Abstract] [Full-text]
125. Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania.
     Behav Brain Res. [Abstract] [Full-text]
126. Genetic approaches to a better understanding of bipolar disorder.
     Pharmacol Ther. [Abstract] [Full-text]
127. Generalizability of evidence-based assessment recommendations for pediatric bipolar disorder.
     Psychol Assess. [Abstract] [Full-text]
128. High Behavioral Approach System (BAS) sensitivity, reward responsiveness, and goal-striving predict first onset of bipolar spectrum disorders: A prospective behavioral high-risk design.
     J Abnorm Psychol. [Abstract] [Full-text]
129. Development and Validation of a Model for Predicting Inpatient Hospitalization.
     Med Care. [Abstract] [Full-text]
130. Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies.
     Front Mol Neurosci, 4: 24. [Abstract] [Full-text]
131. Lithium attenuates pain-related behavior in a rat model of neuropathic pain: Possible involvement of opioid system.
     Pharmacol Biochem Behav. [Abstract] [Full-text]
132. Similarities and differences of white matter connectivity and water diffusivity in bipolar I and II disorder.
     Neurosci Lett. [Abstract] [Full-text]
133. Neural recruitment during failed motor inhibition differentiates youths with bipolar disorder and severe mood dysregulation.
     Biol Psychol. [Abstract] [Full-text]
134. Differential expression of genes encoding neuronal ion-channel subunits in major depression, bipolar disorder and schizophrenia: implications for pathophysiology.
     Int J Neuropsychopharmacol. [Abstract] [Full-text]
135. The Effects of CACNA1C Gene Polymorphism on Spatial Working Memory in Both Healthy Controls and Patients with Schizophrenia or Bipolar Disorder.
     Neuropsychopharmacology. [Abstract] [Full-text]
136. Olanzapine and Benztropine as a Cause of Ischemic Colitis in a 27-year-old Man.
     J Clin Gastroenterol. [Abstract] [Full-text]
137. Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations.
     J Altern Complement Med, 17(10): 881-90. [Abstract] [Full-text]
138. Testing the hypothesis that formal thought disorders are severe mood disorders.
     Schizophr Bull, 37(6): 1136-46. [Abstract] [Full-text]
139. Comparison of D2 dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects.
     Int J Neuropsychopharmacol, 14(10): 1357-66. [Abstract] [Full-text]
140. Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations.
     J Altern Complement Med, 17(10): 881-90. [Abstract] [Full-text]
141. Testing the hypothesis that formal thought disorders are severe mood disorders.
     Schizophr Bull, 37(6): 1136-46. [Abstract] [Full-text]
142. Comparison of D₂ dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects.
     Int J Neuropsychopharmacol, 14(10): 1357-66. [Abstract] [Full-text]
143. Combined analysis of grey matter voxel-based morphometry and white matter tract-based spatial statistics in late-life bipolar disorder.
     J Psychiatry Neurosci, 36(6): 391-401. [Abstract] [Full-text]
144. Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectories.
     Schizophr Bull, 37(6): 1218-28. [Abstract] [Full-text]
145. Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study.
     Br J Psychiatry. [Abstract] [Full-text]
146. Brain Cortical Thickness and Surface Area Correlates of Neurocognitive Performance in Patients with Schizophrenia, Bipolar Disorder, and Healthy Adults.
     J Int Neuropsychol Soc. [Abstract] [Full-text]
147. Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.
     Int J Neuropsychopharmacol. [Abstract] [Full-text]
148. Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study.
     Int J Neuropsychopharmacol. [Abstract] [Full-text]
149. Health Care Resource Utilization and Costs in a Commercially Insured Population of Patients With Bipolar Disorder Type I and Frequent Psychiatric Interventions.
     Clin Ther. [Abstract] [Full-text]
150. Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder.
     J Neural Transm, 118(11): 1621-39. [Abstract] [Full-text]
151. Patients with bipolar disorder show a selective deficit in the episodic simulation of future events.
     Conscious Cogn, 20(4): 1801-7. [Abstract] [Full-text]
152. Glucocorticoid and mineralocorticoid receptor polymorphisms and clinical characteristics in bipolar disorder patients.
     Psychoneuroendocrinology, 36(10): 1460-9. [Abstract] [Full-text]
153. Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder.
     J Neural Transm, 118(11): 1621-39. [Abstract] [Full-text]
154. Patients with bipolar disorder show a selective deficit in the episodic simulation of future events.
     Conscious Cogn, 20(4): 1801-7. [Abstract] [Full-text]
155. Glucocorticoid and mineralocorticoid receptor polymorphisms and clinical characteristics in bipolar disorder patients.
     Psychoneuroendocrinology, 36(10): 1460-9. [Abstract] [Full-text]
156. The genetics of antipsychotic induced tremors: a genome-wide pathway analysis on the STEP-BD SCP sample.
     Am J Med Genet B Neuropsychiatr Genet, 156(8): 975-86. [Abstract] [Full-text]
157. Association analysis of ANK3 gene variants in nordic bipolar disorder and schizophrenia case-control samples.
     Am J Med Genet B Neuropsychiatr Genet, 156(8): 969-74. [Abstract] [Full-text]
158. Impact of DISC1 variation on neuroanatomical and neurocognitive phenotypes.
     Mol Psychiatry, 16(11): 1096-104, 1063. [Abstract] [Full-text]
159. Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview.
     Acta Neurol Scand, 124(6): 390-5. [Abstract] [Full-text]
160. The GA and the GWAS: Using Genetic Algorithms to Search for Multi-locus Associations.
     IEEE/ACM Trans Comput Biol Bioinform. [Abstract] [Full-text]
161. Neural correlates of reversal learning in severe mood dysregulation and pediatric bipolar disorder.
     J Am Acad Child Adolesc Psychiatry, 50(11): 1173-1185.e2. [Abstract] [Full-text]
162. Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder.
     Psychiatr Genet, 21(6): 294-306. [Abstract] [Full-text]
163. Copy number variations in affective disorders and meta-analysis.
     Psychiatr Genet, 21(6): 319-22. [Abstract] [Full-text]
164. Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder.
     Hum Psychopharmacol, 26(7): 451-9. [Abstract] [Full-text]
165. Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state.
     Nord J Psychiatry, 65(6): 419-26. [Abstract] [Full-text]
166. An IRT validation of the Affective Self Rating Scale.
     Nord J Psychiatry, 65(6): 396-402. [Abstract] [Full-text]
167. Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia.
     Neurosci Lett, 505(1): 47-51. [Abstract] [Full-text]
168. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
     Clin Ther, 33(10): 1381-1390.e4. [Abstract] [Full-text]
169. Genuine clinical predictors of bipolar II disorder: an exploration of temporal and contextual characteristics.
     J Affect Disord, 135(1): 419-23. [Abstract] [Full-text]
170. Phenomenology of psychotic mood disorders: lifetime and major depressive episode features.
     J Affect Disord, 135(1): 241-50. [Abstract] [Full-text]
171. The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder.
     J Affect Disord, 135(1): 43-50. [Abstract] [Full-text]
172. Prevalence and factors associated with depressive disorders in an HIV+ rural patient population in southern Uganda.
     J Affect Disord, 135(1): 160-7. [Abstract] [Full-text]
173. Minor physical anomalies in patients with bipolar I disorder and normal controls.
     J Affect Disord, 135(1): 193-200. [Abstract] [Full-text]
174. The impact of temperament in the course of alcohol dependence.
     J Affect Disord, 135(1): 177-83. [Abstract] [Full-text]
175. The effect of comorbid anxiety disorder on neuropsychological function in bipolar II disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(8): 1841-5. [Abstract] [Full-text]
176. Creativity and affective temperaments in non-clinical professional artists: an empirical psychometric investigation.
     J Affect Disord, 135(1): 28-36. [Abstract] [Full-text]
177. Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression.
     J Affect Disord, 135(1): 139-47. [Abstract] [Full-text]
178. Prospective predictors of mood episodes in bipolar disorder.
     J Affect Disord, 135(1): 298-304. [Abstract] [Full-text]
179. Is cerebellar volume related to bipolar disorder?
     J Affect Disord, 135(1): 305-9. [Abstract] [Full-text]
180. Creativity and executive function across manic, mixed and depressive episodes in bipolar I disorder.
     J Affect Disord, 135(1): 292-7. [Abstract] [Full-text]
181. Regulation of the cytoskeleton by Disrupted-in-schizophrenia 1 (DISC1).
     Mol Cell Neurosci, 48(4): 359-64. [Abstract] [Full-text]
182. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
     J Affect Disord, 135(1): 389-94. [Abstract] [Full-text]
183. Social rhythms and vulnerability to bipolar disorder.
     J Affect Disord, 135(1): 384-8. [Abstract] [Full-text]
184. Is risk for mania associated with increased daydreaming as a form of mental imagery?
     J Affect Disord, 135(1): 380-3. [Abstract] [Full-text]
185. MRI exploration of pineal volume in bipolar disorder.
     J Affect Disord, 135(1): 377-9. [Abstract] [Full-text]
186. A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(8): 1820-6. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.